SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024256
Filing Date
2020-05-11
Accepted
2020-05-11 16:32:59
Documents
115
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-10q_20200331.htm   iXBRL 10-Q 3253213
2 EX-10.1 amrx-ex101_72.htm EX-10.1 75816
3 EX-10.2 amrx-ex102_173.htm EX-10.2 169013
4 EX-10.3 amrx-ex103_70.htm EX-10.3 99559
5 EX-10.4 amrx-ex104_71.htm EX-10.4 9650
6 EX-10.6 amrx-ex106_24.htm EX-10.6 103435
7 EX-31.1 amrx-ex311_13.htm EX-31.1 17063
8 EX-31.2 amrx-ex312_10.htm EX-31.2 17117
9 EX-31.3 amrx-ex313_9.htm EX-31.3 17106
10 EX-32.1 amrx-ex321_7.htm EX-32.1 9604
11 EX-32.2 amrx-ex322_8.htm EX-32.2 9544
12 EX-32.3 amrx-ex323_6.htm EX-32.3 9607
  Complete submission text file 0001564590-20-024256.txt   14736105

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA amrx-20200331.xsd EX-101.SCH 102464
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrx-20200331_cal.xml EX-101.CAL 92997
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrx-20200331_def.xml EX-101.DEF 451625
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20200331_lab.xml EX-101.LAB 718838
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20200331_pre.xml EX-101.PRE 612363
86 EXTRACTED XBRL INSTANCE DOCUMENT amrx-10q_20200331_htm.xml XML 3034295
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 20865364
SIC: 2834 Pharmaceutical Preparations